Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sifuvirtide plus HAART in HIV-infected subjects
ChiCTR-TRC-08000238Phase 2Completed
- Sponsor
- Beijing YouAn Hospital
- Start
- Aug 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of sifuvirtide in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoints: Safety indexes and HIV viral load. Started Aug 2007; status: completed.
02
Drugs
sifuvirtide
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on ChiCTR-TRC-08000238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000238.